Pharmacological management of gastrointestinal stromal tumours: an update on the role of sunitinib.
about
Primary gastrointestinal stromal tumors: Current advances in diagnostic biomarkers, prognostic factors and management of its duodenal locationThe outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study.Lymph Node Metastasis in Gastrointestinal Stromal Tumor (GIST): to Report a Case.Lack of Correlation Between Liver Tests Abnormalities and Trabectedin Efficacy in the Treatment of Soft Tissue Sarcoma: a Retrospective StudyGenetics and molecular pathology of gastric malignancy: Development of targeted therapies in the era of personalized medicine.Gaining power and precision by using model-based weights in the analysis of late stage cancer trials with substantial treatment switching.Molecular basis for primary and secondary tyrosine kinase inhibitor resistance in gastrointestinal stromal tumorChanging pathology with changing drugs: tumors of the gastrointestinal tract.The paradigm of personalized therapy in oncology.FGF2 Prevents Sunitinib-Induced Cardiotoxicity in Zebrafish and Cardiomyoblast H9c2 Cells.[Gastrointestinal Stromal Tumors "GIST": status and news through our experience on 54 cases and review of literature].Development of a Nephrotic Syndrome in a Patient with Gastrointestinal Stromal Tumor during a Long-Time Treatment with Sunitinib.Value of pharmacokinetic studies for patients with gastrointestinal stromal tumors.Symptoms from treatment with sunitinib or sorafenib: a multicenter explorative cohort study to explore the influence of patient-reported outcomes on therapy decisions.Patient-reported outcome measures in a pharmacokinetic study with sunitinib, a prospective cohort study.Downregulation of CIC does not associate with overexpression of ETV1 or MAP kinase pathway activation in gastrointestinal stromal tumors.Ultrasound assisted dispersive micro solid-phase extraction of four tyrosine kinase inhibitors from serum and cerebrospinal fluid by using magnetic nanoparticles coated with nickel-doped silica as an adsorbent
P2860
Q26829970-8F3E737B-88FE-4C15-BD0C-4118F9B5C60DQ27851744-2C86A5BC-276F-4BAE-B000-B9BF759FD4A7Q34228774-8381B564-E318-4B72-BC19-4D30E39FB9F2Q35909766-4B932007-031C-4952-BA24-381E3207F6C1Q36162532-7EBDD7EA-C21B-48FF-95AA-4F093D2E5542Q36912430-A83486F6-8F74-47F4-A83B-84C3C4EC3D00Q37813454-DF33A69C-CBAA-4DE7-BCC3-4D08FC9F1D18Q37890208-C7D28F05-9F62-4871-BDB2-DD3CF147C1EFQ37954671-71CCEC5A-631F-4F32-82BA-344B9FBDBDFEQ38907659-90777849-6838-407A-8126-91F8ADF55405Q40042132-5D0B09BD-56A9-4672-AF4F-B584DBEBE9C2Q42061300-53A70A89-A2A6-4138-B414-F37EA91EC0B5Q44529953-F7E29D2D-253E-4052-8FE4-AD4C8E0B48AEQ48081321-75304680-8C87-4225-B5F2-430BB6FDAB65Q49722763-5A36832A-3066-4F2B-9272-DB63A20DBEFBQ54347399-5451089D-EA82-4519-BDD2-16CACB37F31EQ58752788-86BFA05E-0DCC-4C4C-94AD-D53AD749B1A9
P2860
Pharmacological management of gastrointestinal stromal tumours: an update on the role of sunitinib.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacological management of ...... date on the role of sunitinib.
@en
Pharmacological management of ...... date on the role of sunitinib.
@nl
type
label
Pharmacological management of ...... date on the role of sunitinib.
@en
Pharmacological management of ...... date on the role of sunitinib.
@nl
prefLabel
Pharmacological management of ...... date on the role of sunitinib.
@en
Pharmacological management of ...... date on the role of sunitinib.
@nl
P356
P1433
P1476
Pharmacological management of ...... date on the role of sunitinib.
@en
P304
P356
10.1093/ANNONC/MDP291
P577
2009-08-12T00:00:00Z